Quest Diagnostics booth #11069 | May 30 – June 3 | Chicago, IL
Haystack MRD™ is proud to be part of the American Society of Clinical Oncology (ASCO) Annual Meeting, where oncology innovation takes center stage. Join us at booth #11069 to explore how our ctDNA-based assay delivers confidence in detecting even the smallest traces of residual disease.
Why visit Haystack MRD at ASCO?
• Learn how early, confident detection can help guide timely treatment decisions
• Explore real-world insights and data
• Speak directly with our medical, scientific, and commercial experts
See the data
Don’t miss the opportunity to see the science behind the innovation.
- Abstract Title: Circulating tumor DNA (ctDNA) analysis for improved treatment response assessment and prediction of clinical outcomes in patients with esophageal cancer.
- Track: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
- Session Type: Poster Session
- Date and Time: May 31, 9:00 AM – 12:00 PM
- Abstract ID: 4077
We hope to see you there!
Whether you’re new to MRD testing or looking to elevate your current approach, we’re here to support your oncology practice.
Visit the Quest Diagnostics booth #11069 or request a 1:1 meeting in advance by clicking the button below.
Want to join the conversation now?
In this recent video, leading oncologists Dr Doug Flora and Dr Debra Patt discuss how cutting-edge MRD testing is shaping the future of cancer diagnostics and treatment decisions.
